Skip to Main Content
Contribute Try STAT+ Today

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so predictable routine of online calls and deadlines has, of course, returned. To cope, yes, we are firing up the coffee kettle and brewing cups of stimulation. Our choice today is the ever-seasonal pumpkin spice. Feel free to join us. Meanwhile, here is the latest batch of tidbits to get you going. We hope you have a productive day, and do keep in touch if you hear anything interesting. …

Democratic Party lawmakers holding up proposed drug-pricing reform are among the largest beneficiaries of a pharmaceutical industry push to stave off price cuts, a Reuters analysis of public lobbying and campaign data shows. The pharmaceutical industry, which traditionally gives more to Republicans, channeled around 60% of donated campaign funds to Democrats this year. The drug companies have spent over $177 million on lobbying and campaign donations in 2021. Nonprofit political action committees run by Pfizer (PFE) and Amgen (AMGN) and the Pharmaceutical Research and Manufacturers of America trade group were among the biggest donors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment